|
|
|
|
Direct Cost |
Indirect Cost |
|
1F32AI149989-01 |
Role of Chromatin Associated Host Factors in Regulation of Retroviral Replication |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$65,310 |
|
$65,310 |
1K08AI146284-01A1 |
Elucidating the genotypic determinants and phenotypic effects of polymyxin resistance in Klebsiella pneumoniae utilizing CRISPR-Cas9 |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$178,200 |
$14,256 |
$192,456 |
1K23AI150378-01A1 |
Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention Services |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$178,200 |
$13,776 |
$191,976 |
1R01AI143897-01A1 |
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$320,134 |
$194,056 |
$514,190 |
1R01AI149693-01 |
Genetic and ecological determinants of coronavirus recombination |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$316,036 |
$189,581 |
$505,617 |
1R01AI150597-01A1 |
PAG is a novel target in immunotherapy |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$360,117 |
$223,273 |
$583,390 |
1R21AI143417-01A1 |
Targeted next-generation sequencing to enhance detection and genomic characterization of Mycobacterium tuberculosis and high-impact bacterial pathogens among HIV-infected adults with sepsis in Uganda |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$128,581 |
$57,009 |
$185,590 |
1R21AI149657-01 |
Role of T cell-derived amphiregulin in recovery from influenza virus infection |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$150,000 |
$86,360 |
$236,360 |
1R21AI150244-01 |
T Cell Mechanosensing of Microscale Fibers |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$150,000 |
$93,000 |
$243,000 |
1R21AI150813-01 |
Role of heme oxygenase 2 in trafficking and regulation of myristoylated proteins |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$125,000 |
$77,500 |
$202,500 |
1R21AI151469-01 |
Group 1 CD1-restricted human T cells induced by a whole sporozoite-based malaria vaccine |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$175,000 |
$108,500 |
$283,500 |
1R21AI151996-01 |
Identifying quantitative trait loci that regulate enterovirus D68 pathogenesis using the Collaborative Cross |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$150,000 |
$93,000 |
$243,000 |
1R21AI152046-01 |
The Molecular Epidemiology of Staphylococcus aureus Bacteremias During the Opioid Epidemic: A New York Region Perspective |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$104,481 |
$64,778 |
$169,259 |
1R21AI153954-01 |
Flexible InteRvention Strategy for TB prevention (FIRST) study |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$157,299 |
$38,113 |
$195,412 |
1R34AI152962-01 |
Belatacept in De Novo Heart Transplant |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$166,581 |
$103,280 |
$269,861 |
1R56AI150873-01 |
Immune response and tolerance to liver transplants in NHP |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$550,649 |
$310,746 |
$861,395 |
1T32AI148099-01 |
Training in Translational Immunology Research |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$142,246 |
$10,869 |
$153,115 |
1U01AI148309-01 |
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$299,529 |
$185,708 |
$485,237 |
1U01AI150680-01 |
Modeling the ecology of tissue-resident T cells |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$686,870 |
$299,143 |
$986,013 |
1U01AI152881-01 |
Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure |
COLUMBIA UNIVERSITY HEALTH SCIENCES |
NIAID |
$777,024 |
$481,755 |
$1,258,779 |